Cover the Bases

Advances in sequencing technology now make it possible to obtain the sequence of entire genomes. SpectruMedix Corp. of State College, Pa., continues this trend with the introduction of the SCE9610, an automated 96-capillary instrument for high-throughput DNA sequencing, fragment analysis, and genotyping. The science behind the SCE9610 is based on award-winning technology developed by Edward Yeung at the Ames Laboratory at Iowa State University.1 The SCE9610 uses a charge-coupled device (CCD) cam

Written byAileen Constans
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Advances in sequencing technology now make it possible to obtain the sequence of entire genomes. SpectruMedix Corp. of State College, Pa., continues this trend with the introduction of the SCE9610, an automated 96-capillary instrument for high-throughput DNA sequencing, fragment analysis, and genotyping. The science behind the SCE9610 is based on award-winning technology developed by Edward Yeung at the Ames Laboratory at Iowa State University.1 The SCE9610 uses a charge-coupled device (CCD) camera to record laser-excited fluorescence simultaneously from each capillary. According to Thomas Kane, senior scientist at SpectruMedix, the SCE9610 is currently the "largest-capacity system commercially available today." It can run six trays of 96 samples unattended for up to 12 hours.

Kane notes that the SCE9610 represents an improvement over other capillary-based sequencing systems in three respects: It is robust and reliable, offers no possibility of sample cross-contamination, and provides a high degree of flexibility with respect to software, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies